vs

Side-by-side financial comparison of Inspire Medical Systems, Inc. (INSP) and PROCORE TECHNOLOGIES, INC. (PCOR). Click either name above to swap in a different company.

PROCORE TECHNOLOGIES, INC. is the larger business by last-quarter revenue ($349.1M vs $269.1M, roughly 1.3× Inspire Medical Systems, Inc.). Inspire Medical Systems, Inc. runs the higher net margin — 50.6% vs -10.8%, a 61.3% gap on every dollar of revenue. On growth, PROCORE TECHNOLOGIES, INC. posted the faster year-over-year revenue change (15.6% vs 12.2%). PROCORE TECHNOLOGIES, INC. produced more free cash flow last quarter ($109.2M vs $41.8M). Over the past eight quarters, Inspire Medical Systems, Inc.'s revenue compounded faster (28.1% CAGR vs 13.8%).

Inspire Medical Systems, Inc. is a medical technology firm that develops, manufactures and commercializes implantable neurostimulation solutions for obstructive sleep apnea. Its core product serves patients intolerant to CPAP therapy, with main markets across North America, Europe, and select Asia-Pacific regions, operating in sleep medicine and otolaryngology segments.

Procore Technologies is an American construction management software as a service company founded in 2002, with headquarters in Carpinteria, California. Procore hosts a platform to connect those involved in the construction industry on a global platform. The software allows for the creation of simplified workflows and displays a consolidated view of construction products that includes the tracking of tasks, management of project workflows, and scheduling.

INSP vs PCOR — Head-to-Head

Bigger by revenue
PCOR
PCOR
1.3× larger
PCOR
$349.1M
$269.1M
INSP
Growing faster (revenue YoY)
PCOR
PCOR
+3.3% gap
PCOR
15.6%
12.2%
INSP
Higher net margin
INSP
INSP
61.3% more per $
INSP
50.6%
-10.8%
PCOR
More free cash flow
PCOR
PCOR
$67.4M more FCF
PCOR
$109.2M
$41.8M
INSP
Faster 2-yr revenue CAGR
INSP
INSP
Annualised
INSP
28.1%
13.8%
PCOR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
INSP
INSP
PCOR
PCOR
Revenue
$269.1M
$349.1M
Net Profit
$136.1M
$-37.6M
Gross Margin
86.6%
80.1%
Operating Margin
17.1%
-12.3%
Net Margin
50.6%
-10.8%
Revenue YoY
12.2%
15.6%
Net Profit YoY
286.4%
39.6%
EPS (diluted)
$4.57
$-0.25

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
INSP
INSP
PCOR
PCOR
Q4 25
$269.1M
$349.1M
Q3 25
$224.5M
$338.9M
Q2 25
$217.1M
$323.9M
Q1 25
$201.3M
$310.6M
Q4 24
$239.7M
$302.0M
Q3 24
$203.2M
$295.9M
Q2 24
$195.9M
$284.3M
Q1 24
$164.0M
$269.4M
Net Profit
INSP
INSP
PCOR
PCOR
Q4 25
$136.1M
$-37.6M
Q3 25
$9.9M
$-9.1M
Q2 25
$-3.6M
$-21.1M
Q1 25
$3.0M
$-33.0M
Q4 24
$35.2M
$-62.3M
Q3 24
$18.5M
$-26.4M
Q2 24
$9.8M
$-6.3M
Q1 24
$-10.0M
$-11.0M
Gross Margin
INSP
INSP
PCOR
PCOR
Q4 25
86.6%
80.1%
Q3 25
85.8%
79.7%
Q2 25
84.0%
79.1%
Q1 25
84.7%
79.1%
Q4 24
85.0%
81.2%
Q3 24
84.1%
81.4%
Q2 24
84.8%
83.1%
Q1 24
84.9%
83.0%
Operating Margin
INSP
INSP
PCOR
PCOR
Q4 25
17.1%
-12.3%
Q3 25
4.3%
-4.4%
Q2 25
-1.5%
-9.3%
Q1 25
-0.7%
-11.7%
Q4 24
13.3%
-21.9%
Q3 24
7.0%
-12.3%
Q2 24
2.6%
-5.2%
Q1 24
-9.3%
-7.0%
Net Margin
INSP
INSP
PCOR
PCOR
Q4 25
50.6%
-10.8%
Q3 25
4.4%
-2.7%
Q2 25
-1.7%
-6.5%
Q1 25
1.5%
-10.6%
Q4 24
14.7%
-20.6%
Q3 24
9.1%
-8.9%
Q2 24
5.0%
-2.2%
Q1 24
-6.1%
-4.1%
EPS (diluted)
INSP
INSP
PCOR
PCOR
Q4 25
$4.57
$-0.25
Q3 25
$0.34
$-0.06
Q2 25
$-0.12
$-0.14
Q1 25
$0.10
$-0.22
Q4 24
$1.17
$-0.42
Q3 24
$0.60
$-0.18
Q2 24
$0.32
$-0.04
Q1 24
$-0.34
$-0.08

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
INSP
INSP
PCOR
PCOR
Cash + ST InvestmentsLiquidity on hand
$308.3M
$768.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$781.2M
$1.3B
Total Assets
$907.3M
$2.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
INSP
INSP
PCOR
PCOR
Q4 25
$308.3M
$768.5M
Q3 25
$322.6M
$684.0M
Q2 25
$300.9M
$620.9M
Q1 25
$369.2M
$566.7M
Q4 24
$445.5M
$775.4M
Q3 24
$411.0M
$756.9M
Q2 24
$439.7M
$735.4M
Q1 24
$441.4M
$744.6M
Stockholders' Equity
INSP
INSP
PCOR
PCOR
Q4 25
$781.2M
$1.3B
Q3 25
$666.5M
$1.2B
Q2 25
$677.8M
$1.2B
Q1 25
$635.7M
$1.2B
Q4 24
$689.7M
$1.3B
Q3 24
$696.6M
$1.3B
Q2 24
$638.1M
$1.3B
Q1 24
$589.0M
$1.2B
Total Assets
INSP
INSP
PCOR
PCOR
Q4 25
$907.3M
$2.2B
Q3 25
$807.7M
$2.1B
Q2 25
$802.2M
$2.0B
Q1 25
$730.8M
$1.9B
Q4 24
$808.4M
$2.1B
Q3 24
$796.2M
$2.0B
Q2 24
$728.4M
$2.0B
Q1 24
$685.8M
$1.9B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
INSP
INSP
PCOR
PCOR
Operating Cash FlowLast quarter
$52.5M
$114.9M
Free Cash FlowOCF − Capex
$41.8M
$109.2M
FCF MarginFCF / Revenue
15.5%
31.3%
Capex IntensityCapex / Revenue
4.0%
1.6%
Cash ConversionOCF / Net Profit
0.39×
TTM Free Cash FlowTrailing 4 quarters
$78.5M
$282.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
INSP
INSP
PCOR
PCOR
Q4 25
$52.5M
$114.9M
Q3 25
$68.5M
$88.5M
Q2 25
$2.7M
$30.8M
Q1 25
$-6.7M
$66.0M
Q4 24
$69.2M
$29.1M
Q3 24
$52.3M
$39.3M
Q2 24
$-78.0K
$58.7M
Q1 24
$8.9M
$69.1M
Free Cash Flow
INSP
INSP
PCOR
PCOR
Q4 25
$41.8M
$109.2M
Q3 25
$58.1M
$83.1M
Q2 25
$-6.3M
$27.9M
Q1 25
$-15.1M
$62.0M
Q4 24
$62.2M
$17.4M
Q3 24
$44.3M
$35.7M
Q2 24
$-12.5M
$56.8M
Q1 24
$-2.8M
$67.1M
FCF Margin
INSP
INSP
PCOR
PCOR
Q4 25
15.5%
31.3%
Q3 25
25.9%
24.5%
Q2 25
-2.9%
8.6%
Q1 25
-7.5%
20.0%
Q4 24
25.9%
5.8%
Q3 24
21.8%
12.1%
Q2 24
-6.4%
20.0%
Q1 24
-1.7%
24.9%
Capex Intensity
INSP
INSP
PCOR
PCOR
Q4 25
4.0%
1.6%
Q3 25
4.6%
1.6%
Q2 25
4.1%
0.9%
Q1 25
4.2%
1.3%
Q4 24
2.9%
3.9%
Q3 24
3.9%
1.2%
Q2 24
6.3%
0.7%
Q1 24
7.1%
0.8%
Cash Conversion
INSP
INSP
PCOR
PCOR
Q4 25
0.39×
Q3 25
6.90×
Q2 25
Q1 25
-2.24×
Q4 24
1.96×
Q3 24
2.83×
Q2 24
-0.01×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

INSP
INSP

Segment breakdown not available.

PCOR
PCOR

US$298.3M85%
Non Us$50.9M15%

Related Comparisons